Last reviewed · How we verify

NCT05482178

The Association of Resistance Exercise With the Inflammasome Activation in Obesity Subjects

Status unknown NA Last updated 1 August 2022
What this trial tests

NA trial testing Resistance exercise training plus hypocaloric diet in Physical Activity in 20 participants. Status unknown.

Timeline
31 May 2022
Primary endpoint
15 August 2022
16 December 2022

Quick facts

Lead sponsorElisa Barron-Cabrera
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment20
Start date31 May 2022
Primary completion15 August 2022
Estimated completion16 December 2022
Sites1 location across Mexico

Drugs / interventions tested

Conditions studied

Sponsor

Elisa Barron-Cabrera

Who can join

Adults 25 to 50, any sex, with Physical Activity or Resistance Exercise. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The intervention study consist in 3 months of follow up to evaluate the effect of resistance exercise on NLRP3 and interleukin-18 (IL-18) gene expression, and IL-18 and IL-1b cytokines levels in obese subjects, due to, the current evidence has been suggested that aerobic physical exercise could reduce the low-grade chronic inflammation through the downregulation of the NLRP3 inflammasome in obesity subjects, however, there are not enough evidence with resistance protocol. The investigator randomized into two intervention groups: a) group with resistance exercise training plus hypocaloric diet, and b) group with hypocaloric diet. The blood sample was taken fasting at baseline and final intervention (3rd month). The serum was separated for biochemical analyzes and the quantification of cytokines levels. The RNA was obtained from leukocytes to expression assay.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. NLRP3 inflammasome: a key player in the pathogenesis of life-style disorders.
    Ramachandran R, Manan A, Kim J, Choi S. · · 2024 · cited 67× · PMID 38945951 · DOI 10.1038/s12276-024-01261-8

Verify or expand the search:

Other recruiting trials for Physical Activity

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05482178.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing